Theoretical basis and search for new methods of cardiac arrhythmias' pathogenetic therapy
Clicks: 308
ID: 100681
2005
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
30.0
/100
308 views
60 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #1 of 3 articles by views in Российский кардиологический журнал
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Efficacy of cardiac arrhythmias (CA) pharmacotherapy does not exceed 70%; incidence of adverse effects, causing treatment discontinuation, is as high as 10-30%. The need for CA pharmacotherapy improvement is obvious. The authors propose new methods for CA pathogenetic treatment, based on normalization of barrier and distributional sarcolemma functions, and intracellular ion dysbalance correction. Antiarrhythmics normalizing ion channel function should be combined with membrano-protective agents (rhythmocor, salmagin, etc.).
| Reference Key |
moroz2005theoretical
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Moroz, V. M.;Lipnitsky, T. N.; |
| Journal | Российский кардиологический журнал |
| Year | 2005 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.